SuPAR: a potential predictive biomarker for acute kidney injury

Nature Reviews Nephrology, Published online: 08 April 2020; doi:10.1038/s41581-020-0276-7New data suggest that plasma soluble urokinase receptor (suPAR) might be a predictive biomarker and potential therapeutic target for acute kidney injury (AKI). However, many questions remain regarding the potential of suPAR to inform clinical decision making, identify patients for enrolment in clinical trials and add to the understanding of AKI pathogenesis.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Source Type: research